SRSF1

Across TCGA pan-cancer cohorts, SRSF1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SRSF1 data layer compared with 24 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher SRSF1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated SRSF1 expression acts as an unfavorable survival marker, although some lineages such as COAD and LUAD show a favorable association.

COAD, HNSC, and LUAD are the cancer types where SRSF1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	III,IV	1.000	0.897	.044	12	view →
HNSC	OS	Median	IV	0.726	0.934	.007	5	view →
LUAD	DFS	Quartile	All	0.972	0.752	.024	3	view →
LSCC	DFS	Median	III,IV	0.882	1.000	.048	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

SRSF1–COAD (DFS)

Open the COAD breakdown →